News

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...
Abcuro appointed former Priovant Therapeutics exec Courtney Cupples as chief commercial officer. Innospera Pharma appointed ...
U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it was \"plagued ...
Blueprint specializes in systemic mastocytosis, a rare immunological disease, and other Kit-driven diseases. With this ...
SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.
The National Agency for Food and Drug Administration and Control (NAFDAC) has banned an unregistered batch of the ...